Literature DB >> 18502183

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders.

John J Barry1, Alan B Ettinger, Peggy Friel, Frank G Gilliam, Cynthia L Harden, Bruce Hermann, Andres M Kanner, Rochelle Caplan, Sigita Plioplys, Jay Salpekar, David Dunn, Joan Austin, Jana Jones.   

Abstract

Affective disorders in people with epilepsy (PWE) have become increasingly recognized as a primary factor in the morbidity and mortality of epilepsy. To improve the recognition and treatment of affective disorders in PWE, an expert panel comprising members from the Epilepsy Foundation's Mood Disorders Initiative have composed a Consensus Statement. This document focuses on depressive disorders in particular and reviews the appearance and treatment of the disorder in children, adolescents, and adults. Idiosyncratic aspects of the appearance of depression in this population, along with physiological and cognitive issues and barriers to treatment, are reviewed. Finally, a suggested approach to the diagnosis of affective disorders in PWE is presented in detail. This includes the use of psychometric tools for diagnosis and a stepwise algorithmic approach to treatment. Recommendations are based on the general depression literature as well as epilepsy-specific studies. It is hoped that this document will improve the overall detection and subsequent treatment of affective illnesses in PWE.

Entities:  

Mesh:

Year:  2008        PMID: 18502183     DOI: 10.1016/j.yebeh.2008.04.005

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  27 in total

Review 1.  A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders.

Authors:  Surabhi Thapliyal; Tanveer Singh; Shailendra Handu; Manisha Bisht; Puja Kumari; Priyanka Arya; Pallavi Srivastava; Ravi Gandham
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

2.  Depression in epilepsy: mechanisms and therapeutic approach.

Authors:  Marco Mula; Bettina Schmitz
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

Review 3.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

4.  Seizure susceptibility and epileptogenesis in a rat model of epilepsy and depression co-morbidity.

Authors:  S Alisha Epps; Kroshona D Tabb; Sharon J Lin; Alexa B Kahn; Martin A Javors; Katherine A Boss-Williams; Jay M Weiss; David Weinshenker
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

5.  Identification of risk for severe psychiatric comorbidity in pediatric epilepsy.

Authors:  Jana E Jones; Prabha Siddarth; Dace Almane; Suresh Gurbani; Bruce P Hermann; Rochelle Caplan
Journal:  Epilepsia       Date:  2016-10-14       Impact factor: 5.864

Review 6.  [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2014-05-20

Review 7.  Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan.

Authors:  Jack J Lin; Marco Mula; Bruce P Hermann
Journal:  Lancet       Date:  2012-09-29       Impact factor: 79.321

Review 8.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 9.  [Medical treatment of epilepsy: hidden dimensions].

Authors:  J Bauer; C Kronisch
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

10.  Computer-assisted cognitive behavioral therapy for children with epilepsy and anxiety: a pilot study.

Authors:  Jacquelyn B Blocher; Mayu Fujikawa; Connie Sung; Daren C Jackson; Jana E Jones
Journal:  Epilepsy Behav       Date:  2013-02-01       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.